NASDAQ:MMSI - Merit Medical Systems Stock Price, Price Target & More

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its earnings results on Wednesday, April, 25th. The medical instruments supplier reported $0.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.29 by $0.02. The medical instruments supplier earned $203.04 million during the quarter, compared to the consensus estimate of $192.60 million. Merit Medical Systems had a net margin of 2.37% and a return on equity of 10.01%. Merit Medical Systems's revenue was up 18.7% on a year-over-year basis. During the same period last year, the business posted $0.28 EPS. View Merit Medical Systems' Earnings History.

Merit Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for Merit Medical Systems.

12 analysts have issued 12-month price targets for Merit Medical Systems' stock. Their forecasts range from $44.00 to $62.00. On average, they expect Merit Medical Systems' stock price to reach $51.00 in the next year. View Analyst Ratings for Merit Medical Systems.

Some companies that are related to Merit Medical Systems include Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Insulet (PODD), Globus Medical (GMED), Penumbra (PEN), Haemonetics (HAE), Cantel Medical (CMD), NuVasive (NUVA), Novocure (NVCR), Nevro (NVRO), Irhythm Technologies (IRTC), Mazor Robotics (MZOR), Glaukos (GKOS) and Luminex (LMNX).

Headlines about MMSI stock have been trending positive recently, Accern reports. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.26 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 45.72 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Merit Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.61%), Dimensional Fund Advisors LP (4.72%), Eagle Asset Management Inc. (3.73%), Rockefeller Capital Management L.P. (1.55%), Loomis Sayles & Co. L P (1.31%) and Rothschild Asset Management Inc. (1.27%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Institutional Ownership Trends for Merit Medical Systems.

MMSI stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Russell Investments Group Ltd., Dalton Greiner Hartman Maher & Co., JPMorgan Chase & Co., Dimensional Fund Advisors LP, Frontier Capital Management Co. LLC, Timpani Capital Management LLC and Fiera Capital Corp. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras and Richard W Edelman. View Insider Buying and Selling for Merit Medical Systems.

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Rockefeller Capital Management L.P., BlackRock Inc., Allianz Asset Management GmbH, Allianz Asset Management GmbH, The Manufacturers Life Insurance Company , Mackay Shields LLC, American Century Companies Inc. and Sei Investments Co.. View Insider Buying and Selling for Merit Medical Systems.

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMSI stock can currently be purchased for approximately $50.40.

Merit Medical Systems has a market capitalization of $2.52 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]